Clinical Trial Update: Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing four quadrants transverse abdominus plane block with plain and liposomal bupivacaine versus thoracic epidermal analgesia in CRS-HIPEC …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)
• plain bupivacaine (bupivacaine)
• thoracic epidermal analgesia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peritoneal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2022-02-18